Emmaus Life Sciences, Inc., a commercial-stage biopharmaceutical company, discovers, develops, markets, and sells treatments and therapies primarily for rare and orphan diseases in the United States and internationally. The company's lead candidate is Endari, an L-glutamine oral powder to reduce...
474 insider purchases on record · latest filing 2026-09-02.
Insiders have also filed 2 sale transactions at EMMA.